Insiders · BCYC

Janice Bourque

Director at Bicycle Therapeutics PLC (BCYC)

Janice Bourque has filed 5 insider reports with the SEC since January 2022, as director at Bicycle Therapeutics PLC (BCYC). The latest filing, on January 7, 2026, reports grant or award at Bicycle Therapeutics PLC (BCYC).

Filings
5
Companies
1
Bought on market
None
Sold on market
None

Companies where Janice Bourque is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Bicycle Therapeutics PLC logo
BCYC
Bicycle Therapeutics PLC
Director32,500$3.20Jan 7, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Janice Bourque with

Other insiders at the same companies

Questions about Janice Bourque

What is Janice Bourque's role at Bicycle Therapeutics PLC?
Janice Bourque reports to the SEC as director at Bicycle Therapeutics PLC (BCYC), according to the latest filing on January 7, 2026.
How many shares does Janice Bourque own?
After the latest filing that states it, Janice Bourque directly owned 32,500 shares of Bicycle Therapeutics PLC (BCYC). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Janice Bourque bought or sold stock recently?
No open-market purchases or sales by Janice Bourque are on file. The filings report grant or award.
How do I get alerts when Janice Bourque files?
Follow Janice Bourque on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Janice Bourque (SEC CIK 0001783330). Totals count each trade once, skipping amendments whose original is on file, from Jan 5, 2022 on. View on SEC EDGAR